Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1222 (LINC01222)

Target
LINC01222
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 1222 (LINC01222) is a human long intergenic non-coding RNA (lincRNA), which means it is an RNA transcript longer than 200 nucleotides that does not overlap any protein-coding gene and lacks protein-coding potential[3][5]. It is encoded in the human genome as gene 102800316 (NCBI Gene) and is also referenced by the alias TCONS_00000112[3]. LINC01222 belongs to a large class of lincRNAs known to regulate gene expression at various levels, including chromatin modification, RNA stability, and transcription, through a range of mechanisms[5]. There are no specific reports directly linking LINC01222 to particular biological pathways, disease roles, or therapeutically actionable functions at this time, and it is not considered a therapeutic target[1][3][5]. Other lincRNAs are established as regulators of cell fate and disease progression, but the unique contributions of LINC01222 remain to be elucidated.

Other names
TCONS_00000112
02

Biological functions

Not clearly establishedlincRNAs in general are involved in chromatin remodeling, gene expression regulation, and transcriptional controlspecific functions for LINC01222 have not been reported
03

Disease associations

No direct disease associations documented for LINC01222the general class of lincRNAs can be involved in cancer and other diseases

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1222 (LINC01222).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1222 (LINC01222).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call